SCHEMBL22962192

SCHEMBL22962192

CC(C)(C)OC(=O)N[C@@H](CC(N)=O)C(=O)NC1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
CTSS P25774 3/20 0.41
CTSK P43235 3/20 0.41
SCN9A Q15858 4/20 0.38
HRH2 P25021 2/20 0.37
HRH1 P35367 2/20 0.37
EPHX1 P07099 2/20 0.37
REN P00797 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37
BACE1 P56817 2/20 0.36
AAK1 Q2M2I8 1/20 0.36
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22961956 0.83 HDAC4 (0.42) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL22962032 0.81 HDAC4 (0.42) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL785870 0.81 CTSS (0.56) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL19734820 0.79 KMT2A (0.48) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL28737415 0.79 KMT2A (0.48) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL22962320 0.79 HDAC4 (0.43) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL7513684 0.77 CTSK (0.51) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL8133237 0.77 HDAC4 (0.52) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL8133234 0.77 HDAC4 (0.52) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL25174673 0.76 HDAC4 (0.58) HDAC4HDAC1HDAC6CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092091-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE LIGANDS Humanwell Pharmaceutical US 2025-03-20 US disclosed
US-20210040150-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) 2021-02-11 US disclosed
WO-2021026492-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS Humanwell Pharmaceutical US (US) 2021-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250092091-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE LIGANDS OPRK1, OPRL1, OPRD1 HDAC4 3932/4885HDAC1 4164/4885HDAC6 2336/4885
US-20210040150-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS OPRK1, OPRL1, OPRD1 HDAC4 3969/4885HDAC1 4299/4885HDAC6 2483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.